{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:22:48Z","timestamp":1790871768701,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["91-B-FA09\u20131-4"],"award-info":[{"award-number":["91-B-FA09\u20131-4"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["95\u20132320-B-006\u2013072-MY2"],"award-info":[{"award-number":["95\u20132320-B-006\u2013072-MY2"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["DAMD17\u201303\u20131-0736"],"award-info":[{"award-number":["DAMD17\u201303\u20131-0736"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.molmed.2006.11.006","type":"journal-article","created":{"date-parts":[[2006,12,5]],"date-time":"2006-12-05T07:11:14Z","timestamp":1165302674000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["WW domain-containing oxidoreductase: a candidate tumor suppressor"],"prefix":"10.1016","volume":"13","author":[{"given":"Nan-Shan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Shin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Jie","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamm-Ming","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2006.11.006_bib1","first-page":"2140","article-title":"WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer","volume":"60","author":"Bednarek","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/hmg\/9.11.1651","article-title":"Common chromosomal fragile site FRAD16D sequence: identification of the FOR gene spanning FRAD16D and homozygous deletions and translocation breakpoints in cancer cells","volume":"9","author":"Ried","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2006.11.006_bib3","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1074\/jbc.M007140200","article-title":"Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity","volume":"276","author":"Chang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2006.11.006_bib4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0006-2952(03)00484-2","article-title":"Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses","volume":"66","author":"Chang","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2006.11.006_bib5","first-page":"8629","article-title":"An opposing view on WWOX protein function as a tumor suppressor","volume":"63","author":"Watanabe","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib6","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1158\/0008-5472.CAN-05-1127","article-title":"Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox","volume":"65","author":"Mahajan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib7","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1158\/0008-5472.CAN-05-1022","article-title":"HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor","volume":"65","author":"Lokeshwar","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib8","doi-asserted-by":"crossref","first-page":"30498","DOI":"10.1074\/jbc.M401399200","article-title":"Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease","volume":"279","author":"Sze","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2006.11.006_bib9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/sj.onc.1208124","article-title":"17\u03b2-Estradiol upregulates and activates WOX1\/WWOXv1 and WOX2\/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo","volume":"24","author":"Chang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2006.11.006_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/gcc.10047","article-title":"The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1","volume":"34","author":"Krummel","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.molmed.2006.11.006_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0092-8674(00)00203-8","article-title":"NeW wrinkles for an old domain","volume":"103","author":"Sudol","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2006.11.006_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/pmic.200300632","article-title":"A map of WW domain family interactions","volume":"4","author":"Hu","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.molmed.2006.11.006_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/15216540500389039","article-title":"WW or WoW: the WW domains in a union of bliss","volume":"57","author":"Sudol","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.molmed.2006.11.006_bib14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2004.02.002","article-title":"Pinning down cell signaling, cancer and Alzheimer's disease","volume":"29","author":"Lu","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molmed.2006.11.006_bib15","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/j.1471-4159.2006.03995.x","article-title":"Pin1 in Alzheimer's disease","volume":"98","author":"Butterfield","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2006.11.006_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0009-2797(00)00301-X","article-title":"Forms and functions of human SDR enzymes","volume":"130\u2013132","author":"Oppermann","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.molmed.2006.11.006_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.0959-9673.2005.00427.x","article-title":"Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-\u03b2 peptide alcohol dehydrogenase (ABAD)","volume":"86","author":"Yan","year":"2005","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.molmed.2006.11.006_bib18","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1074\/jbc.M208373200","article-title":"JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis","volume":"278","author":"Chang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2006.11.006_bib19","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1073\/pnas.0400805101","article-title":"Functional association between Wwox tumor suppressor protein and p73, a p53 homolog","volume":"101","author":"Aqeilan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2006.11.006_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neuroscience.2004.07.054","article-title":"Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo","volume":"130","author":"Chen","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmed.2006.11.006_bib21","first-page":"19","article-title":"A potential role of p53 and WOX1 in mitochondrial apoptosis","volume":"9","author":"Chang","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.molmed.2006.11.006_bib22","first-page":"8068","article-title":"WWOX, the FRA16D gene, behaves as a suppressor of tumor growth","volume":"61","author":"Bednarek","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbrc.2006.01.023","article-title":"PKA-mediated protein phosphorylation regulates ezrin\u2013WWOX interaction","volume":"341","author":"Jin","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2006.11.006_bib24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuroscience.2003.12.036","article-title":"Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system","volume":"124","author":"Chen","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmed.2006.11.006_bib25","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1158\/1078-0432.CCR-04-2274","article-title":"WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo","volume":"11","author":"Lai","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10735-006-9046-5","article-title":"WWOX protein expression in normal human tissues","volume":"31","author":"Nunez","year":"2006","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.molmed.2006.11.006_bib27","doi-asserted-by":"crossref","first-page":"43100","DOI":"10.1074\/jbc.M505590200","article-title":"WOX1 is essential for TNF-, UV light-, staurosporine-, and p53-mediated cell death and its tyrosine 33 phosphorylated form binds and stabilizes serine 46-phosphorylated p53","volume":"280","author":"Chang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2006.11.006_bib28","doi-asserted-by":"crossref","first-page":"15611","DOI":"10.1073\/pnas.0505485102","article-title":"WWOX gene restoration prevents lung cancer growth in vitro and in vivo","volume":"102","author":"Fabbri","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2006.11.006_bib29","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1158\/0008-5472.CAN-06-0956","article-title":"A role for the WWOX gene in prostate cancer","volume":"66","author":"Qin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ijc.22073","article-title":"Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity","volume":"120","author":"Cantor","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2006.11.006_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/gcc.20305","article-title":"Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer","volume":"45","author":"Sbrana","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.molmed.2006.11.006_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0168-9525(01)02303-4","article-title":"Fragile and unstable chromosomes in cancer: causes and consequences","volume":"17","author":"Richards","year":"2001","journal-title":"Trends Genet."},{"key":"10.1016\/j.molmed.2006.11.006_bib33","first-page":"37","article-title":"Tumor necrosis factor ligand\u2013receptor superfamily and arthritis","volume":"9","author":"Hsu","year":"2006","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.molmed.2006.11.006_bib34","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-04-2055","article-title":"Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2\u03b3 transcription factor","volume":"64","author":"Aqeilan","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib35","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1158\/0008-5472.CAN-05-1150","article-title":"WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function","volume":"65","author":"Aqeilan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib36","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/sj.onc.1207680","article-title":"WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins","volume":"23","author":"Ludes-Meyers","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2006.11.006_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrm882","article-title":"ERM proteins and merlin: integrators at the cell cortex","volume":"3","author":"Bretscher","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2006.11.006_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000072844","article-title":"WWOX, the common chromosomal fragile site, FRA16D, cancer gene","volume":"100","author":"Ludes-Meyers","year":"2003","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib39","first-page":"29","article-title":"Common fragile genes","volume":"48","author":"Matsuyama","year":"2004","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.molmed.2006.11.006_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1532\/IJH97.03145","article-title":"Alterations of common chromosome fragile sites in hematopoietic malignancies","volume":"79","author":"Ishii","year":"2004","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.molmed.2006.11.006_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2005.07.041","article-title":"Common chromosomal fragile sites and cancer: focus on FRA16D","volume":"232","author":"O\u2019Keefe","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2006.11.006_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2005.06.048","article-title":"Roles of FHIT and WWOX fragile genes in cancer","volume":"232","author":"Iliopoulos","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2006.11.006_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2005.06.049","article-title":"Common fragile sites, extremely large genes, neural development and cancer","volume":"232","author":"Smith","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2006.11.006_bib44","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1038\/sj.onc.1204674","article-title":"Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma","volume":"20","author":"Yakicier","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2006.11.006_bib45","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/sj.onc.1205273","article-title":"Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors","volume":"21","author":"Driouch","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2006.11.006_bib46","first-page":"2258","article-title":"Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma","volume":"62","author":"Kuroki","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib47","first-page":"878","article-title":"WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer","volume":"63","author":"Yendamuri","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib48","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-03-0096","article-title":"The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis","volume":"10","author":"Kuroki","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib49","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1158\/1078-0432.CCR-03-0594","article-title":"Loss of WWOX expression in gastric carcinoma","volume":"10","author":"Aqeilan","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib50","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/ijc.21446","article-title":"Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas","volume":"118","author":"Pimenta","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2006.11.006_bib51","first-page":"940","article-title":"Expression of FRA16D\/WWOX and FRA3B\/FHIT genes in hematopoietic malignancies","volume":"1","author":"Ishii","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mc.20122","article-title":"Expression of common chromosomal fragile site genes, WWOX\/FRA16D and FHIT\/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR","volume":"44","author":"Thavathiru","year":"2005","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.molmed.2006.11.006_bib53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1541-7786.MCR-04-0209","article-title":"Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites","volume":"3","author":"Ishii","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejso.2005.11.002","article-title":"WWOX \u2013 the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis","volume":"32","author":"Pluciennik","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.molmed.2006.11.006_bib55","doi-asserted-by":"crossref","first-page":"11417","DOI":"10.1073\/pnas.191175898","article-title":"WWOX: a candidate tumor suppressor gene involved in multiple tumor types","volume":"98","author":"Paige","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2006.11.006_bib56","first-page":"162","article-title":"Deletion and mutation of WWOX exons 6\u20138 in human non-small cell lung cancer","volume":"25","author":"Zhou","year":"2005","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci"},{"key":"10.1016\/j.molmed.2006.11.006_bib57","first-page":"1681","article-title":"WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear","volume":"26","author":"Gourley","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.molmed.2006.11.006_bib58","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/sj.onc.1208398","article-title":"Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer","volume":"24","author":"Iliopoulos","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2006.11.006_bib59","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.20137","article-title":"The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma","volume":"100","author":"Guler","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.molmed.2006.11.006_bib60","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1038\/sj.onc.1208806","article-title":"FRA16D common chromosomal fragile site oxido-reductase (FOR\/WWOX) protects against the effects of ionizing radiation in Drosophila","volume":"24","author":"O\u2019Keefe","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2006.11.006_bib61","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/sj.cdd.4401722","article-title":"Death penalty for keratinocytes: apoptosis versus cornification","volume":"12","author":"Lippens","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2006.11.006_bib62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrm1619","article-title":"The cornified envelope: a model of cell death in the skin","volume":"6","author":"Candi","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2006.11.006_bib63","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1038\/sj.jid.5700470","article-title":"Expression profiling of UVB response in melanocytes identifies a set of p53-target genes","volume":"126","author":"Yang","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molmed.2006.11.006_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer","volume":"61","author":"Diepgen","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.molmed.2006.11.006_bib65","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.biocel.2005.02.015","article-title":"The sunburn cell: regulation of death and survival of the keratinocyte","volume":"37","author":"Van Laethem","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.molmed.2006.11.006_bib66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2407-5-64","article-title":"WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome","volume":"5","author":"Nunez","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2006.11.006_bib67","first-page":"297","article-title":"Hyaluronidases in tissue invasion","volume":"17","author":"Csoka","year":"1997","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.molmed.2006.11.006_bib68","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2006.11.006_bib69","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.patbio.2004.12.021","article-title":"Hyaluronan metabolism: a major paradox in cancer biology","volume":"53","author":"Stern","year":"2005","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.molmed.2006.11.006_bib70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0945-053X(01)00172-X","article-title":"The six hyaluronidase-like genes in the human and mouse genomes","volume":"20","author":"Csoka","year":"2001","journal-title":"Matrix Biol."},{"key":"10.1016\/j.molmed.2006.11.006_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0304-3835(98)00199-2","article-title":"Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors","volume":"131","author":"St Croix","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2006.11.006_bib72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/jsre.2002.6351","article-title":"Expression of PH-20 in normal and neoplastic breast tissue","volume":"103","author":"Beech","year":"2002","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.molmed.2006.11.006_bib73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2121-3-8","article-title":"Transforming growth factor-\u03b21 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts","volume":"3","author":"Chang","year":"2002","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.molmed.2006.11.006_bib74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-004-1474-x","article-title":"Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status","volume":"89","author":"Nunez","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.molmed.2006.11.006_bib75","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1073\/pnas.0603449103","article-title":"The E3 ubiquitin ligase Itch controls the protein stability of p63","volume":"103","author":"Rossi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491406002656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491406002656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:13:50Z","timestamp":1761462830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491406002656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1471491406002656"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2006.11.006","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WW domain-containing oxidoreductase: a candidate tumor suppressor","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2006.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}